3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise DealThe Motley Fool • 06/18/19
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug FailuresInvestors Business Daily • 06/14/19
Time Is Brain: Bioxytran's Tissue Oxygenation Therapy May Breathe New Life Into Stroke VictimsSeeking Alpha • 06/10/19
Biogen (BIIB) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 05/29/19
Biogen (BIIB) Down 0.3% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 05/24/19
Biogen urges shareholders to reject 'below-market' mini-tender offer from TRC CapitalMarket Watch • 05/20/19
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 04/24/19